Project
Sanofi GCA EFC15068
Aborted ยท 2019 until 2020
Rubbert-Roth Andrea, Neumann Thomas, Bartz-Batliner Mira, Peischl Riana, Sasselli Clelia
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Aborted
Start Date
2019
End Date
2020
Financing
Industry
Brief description/objective
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and
safety of sarilumab in patients with giant cell arteritis